+86-13857813723
News
Home / News / Industry News / How does the size of atomized particles from a compressed nebulizer affect drug absorption?

How does the size of atomized particles from a compressed nebulizer affect drug absorption?

2024-12-11

Compressed nebulizer is one of the important medical devices for treating respiratory diseases, especially common respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It helps patients inhale the drug directly into the lungs by atomizing liquid drugs into fine particles, thereby quickly and effectively relieving symptoms and treating diseases. In this process, the size of the atomized particles plays a vital role. This article will explore the effect of the atomized particle size on the drug absorption effect in the compressed nebulizer.

Definition of atomized particle size
In a compressed nebulizer, the drug is broken down into tiny droplets through the airflow, which are called atomized particles. The size of atomized particles is usually measured in microns (µm). The range of atomized particle size is usually between 1 and 10 microns, and different particle sizes are suitable for different treatment needs. Studies have shown that the size of atomized particles directly affects the deposition location and absorption efficiency of the drug.

Particle size and drug deposition site
The size of the atomized particles determines its deposition location in the respiratory tract. Based on the size of the particles, the deposition sites of drugs in the respiratory tract can be divided into three main areas:

Upper respiratory tract (nose and throat): Large particles (>10 µm) tend to be deposited in the nose and throat. These particles cannot penetrate deep into the lungs, so they are usually used to treat upper respiratory tract diseases such as rhinitis and cough.

Mid-airway (bronchi): Medium-sized particles (5-10 µm) are mainly deposited in the middle of the bronchi. These particles are suitable for treating diseases such as bronchitis and asthma.

Lower respiratory tract (alveoli): Smaller particles (<5 µm) can pass through the upper respiratory tract and mid-airway, penetrate deep into the alveoli and be absorbed. These fine particles are particularly important for treating deep lung diseases such as pneumonia, COPD and acute asthma attacks.

Therefore, the absorption effect of the drug is closely related to the size of the atomized particles. Particles that are too large may not be able to enter the deep lungs and can only stay in the upper respiratory tract, reducing the therapeutic effect. Particles that are too small may be exhaled, wasting drugs and affecting the efficacy.

Particle size and drug absorption efficiency
The size of the particle not only determines the location of its deposition, but also directly affects the absorption efficiency of the drug. Smaller particles (<5 µm) can penetrate deep into the lungs and contact more alveolar surface area, thereby increasing the absorption rate of the drug. This is crucial for drugs that require rapid action and deep absorption. For example, inhaled steroids and bronchodilators need to enter the lungs through smaller particles to provide better therapeutic effects.

On the other hand, although larger particles do not penetrate deeply into the lungs, they can be deposited in the upper respiratory tract or mid-airway, and they also have good therapeutic effects for certain upper respiratory tract infections (such as pharyngitis and bronchitis). For these diseases, drug particles do not need to be too small, so medium particle sizes (5-10 µm) are more suitable.

Relationship between aerosol particle size and drug type
Different types of drugs have different requirements for the size of aerosol particles. For example, for short-acting bronchodilators or rapid relief drugs (such as salbutamol), the particles should be moderate, which can quickly reach the lower respiratory tract and produce high concentrations in the alveoli. For slow-acting drugs (such as steroids), smaller particles are more conducive to long-term deposition in the lungs, ensuring that the drug can work for a long time.

In addition, the absorption of some antibiotics or antiviral drugs is also affected by particle size. The smaller the atomized particles, the longer the drug stays in the alveoli, thereby enhancing the antibacterial or antiviral effect of the drug.

How to adjust the nebulizer to optimize particle size
The atomized particle size of the nebulizer can usually be controlled by adjusting the pressure and flow of the device and the type of atomizer head used. For patients who need deep lung treatment, it is important to choose a nebulizer that can produce small particles (<5 µm) so that the drug can pass through the lung airways and enter the deeper alveoli to ensure effective absorption.

Modern compressed nebulizers usually have adjustable functions that allow users to adjust the size of the atomized particles according to treatment needs. For example, some nebulizers are equipped with specially designed nozzles or atomizer heads to optimize the distribution and size of particles under different treatment conditions. In this way, the nebulizer can provide patients with tailored treatment plans and improve the absorption effect of drugs.

Share News

Be the First to Know

For exclusive deals and latest offers, sign up by entering your email address below.